What does this research mean for the field?

In acute myeloid leukemia, synergistic dysfunction in chromatin remodeling and Polycomb-mediated repression enables a core transcriptional network (centered on AFF1, TAL1, IKZF1, and GATA1) that hijacks TP53/FoxO signaling to drive oncogenesis. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to identify the transcriptional networks influenced by epigenetic changes in acute myeloid leukemia.

June 1, 2026Discover OncologyOpen Access

An integrated multi-omics analysis reveals a core epigenetically-activated transcriptional network driving oncogenic signaling in acute myeloid leukemia

View Full Paper

Ask AI

Bookmark

Authors

LZLihua ZengSouth China Normal University HLHaohao LeiNew Huadu Business School JBJingnan BiNew Huadu Business School

Discussion

Member takes

Implication

Randomized trial uncovers a core transcriptional network in acute myeloid leukemia, suggesting new treatment targets.

Key Points

This research aims to identify the transcriptional networks influenced by epigenetic changes in acute myeloid leukemia.
Employing an integrative bioinformatics strategy using transcriptomic data from distinct AML cell types.
Analyzing differentially expressed genes to create a 32-gene AML signature.
Validating core gene expression patterns through functional enrichment and PPI network analyses.
The 32-gene AML signature demonstrated strong enrichment in hematopoietic differentiation pathways.
Identified nine key hubs influencing transcriptional activity, revealing expression heterogeneity across AML subtypes.
Perturbation analysis indicated significant roles for chromatin remodeling and Polycomb repression in oncogenic signaling.

Cite This Study

Zeng et al. (2026) studied this question.

synapsesocial.com/papers/6a1d226d02fbce91306382ac https://doi.org/10.1007/s12672-026-05308-2

View Full Paper

Ask AI

Bookmark

June 1, 2026Discover OncologyOpen Access

An integrated multi-omics analysis reveals a core epigenetically-activated transcriptional network driving oncogenic signaling in acute myeloid leukemia

View Full Paper

Ask AI

Bookmark

Authors

LZLihua ZengSouth China Normal University HLHaohao LeiNew Huadu Business School JBJingnan BiNew Huadu Business School

Discussion

Member takes

Implication

Randomized trial uncovers a core transcriptional network in acute myeloid leukemia, suggesting new treatment targets.

Key Points

This research aims to identify the transcriptional networks influenced by epigenetic changes in acute myeloid leukemia.
Employing an integrative bioinformatics strategy using transcriptomic data from distinct AML cell types.
Analyzing differentially expressed genes to create a 32-gene AML signature.
Validating core gene expression patterns through functional enrichment and PPI network analyses.
The 32-gene AML signature demonstrated strong enrichment in hematopoietic differentiation pathways.
Identified nine key hubs influencing transcriptional activity, revealing expression heterogeneity across AML subtypes.
Perturbation analysis indicated significant roles for chromatin remodeling and Polycomb repression in oncogenic signaling.

Cite This Study

Zeng et al. (2026) studied this question.

synapsesocial.com/papers/6a1d226d02fbce91306382ac https://doi.org/10.1007/s12672-026-05308-2

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark